BRPI0813450A2 - Composto, composição, combinação, formulação farmacêutica, e, métodos para inibir uma enzima, para exterminar ou prevenir o crescimento de um microorganismo e para tratar e/ou prevenir uma doença em um animal - Google Patents

Composto, composição, combinação, formulação farmacêutica, e, métodos para inibir uma enzima, para exterminar ou prevenir o crescimento de um microorganismo e para tratar e/ou prevenir uma doença em um animal

Info

Publication number: BRPI0813450A2
Authority: BR; Brazil
Prior art keywords: prevent; extermine; microorganism; inhibit; enzyme
Prior art date: 2007-06-20

Application number

BRPI0813450-2A2A

Other languages

English (en)

Inventor

Stephen J Baker

Vincent S Hernandez

Rashmi Sharma

James A Nieman

Tsutoma Akama

Yong-Kang Zhang

Jacob J Plattner

Michael Richard Kevin Alley

Rajeshwar Singh

Minh Ha

Xiaosong Lu

El Mehdi Keramane

Huchen Zhou

Yi Xia

James G Philips

Rahim Mohammad

Original Assignee

Anacor Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-20

Filing date

2008-06-19

Publication date

2014-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40156702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0813450(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-19 Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc

2014-12-30 Publication of BRPI0813450A2 publication Critical patent/BRPI0813450A2/pt

2019-05-07 Publication of BRPI0813450B1 publication Critical patent/BRPI0813450B1/pt

2021-05-25 Publication of BRPI0813450B8 publication Critical patent/BRPI0813450B8/pt

Links

-1 COMBINATION Substances 0.000 title 1
102000004190 Enzymes Human genes 0.000 title 1
108090000790 Enzymes Proteins 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
238000000034 method Methods 0.000 title 1
244000005700 microbiome Species 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BRPI0813450A 2007-06-20 2008-06-19 composto, formulação farmacêutica, e, usos do composto BRPI0813450B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US94529407P	2007-06-20	2007-06-20
US60/945,294		2007-06-20
US4117808P	2008-03-31	2008-03-31
US61/041,178		2008-03-31
PCT/US2008/067550 WO2008157726A1 (en)	2007-06-20	2008-06-19	Boron-containing small molecules

Publications (3)

Publication Number	Publication Date
BRPI0813450A2 true BRPI0813450A2 (pt)	2014-12-30
BRPI0813450B1 BRPI0813450B1 (pt)	2019-05-07
BRPI0813450B8 BRPI0813450B8 (pt)	2021-05-25

Family

ID=40156702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0813450A BRPI0813450B8 (pt)	2007-06-20	2008-06-19	composto, formulação farmacêutica, e, usos do composto

Country Status (29)

Country	Link
US (4)	US7816344B2 (pt)
EP (1)	EP2164331B1 (pt)
JP (3)	JP5530923B2 (pt)
KR (3)	KR20150100945A (pt)
CN (2)	CN104017008A (pt)
AR (1)	AR067105A1 (pt)
AU (1)	AU2008265630B2 (pt)
BR (1)	BRPI0813450B8 (pt)
CA (1)	CA2692135C (pt)
CL (1)	CL2008001855A1 (pt)
CO (1)	CO6251209A2 (pt)
CR (1)	CR11224A (pt)
DK (1)	DK2164331T3 (pt)
DO (1)	DOP2009000281A (pt)
EA (1)	EA020530B1 (pt)
ES (1)	ES2655299T3 (pt)
IL (1)	IL202379A (pt)
JO (1)	JO3396B1 (pt)
MA (1)	MA31675B1 (pt)
MX (1)	MX347688B (pt)
MY (1)	MY162692A (pt)
NO (1)	NO2164331T3 (pt)
NZ (1)	NZ582706A (pt)
PE (1)	PE20090840A1 (pt)
SG (1)	SG182219A1 (pt)
TW (1)	TW200911822A (pt)
UY (1)	UY31171A1 (pt)
WO (1)	WO2008157726A1 (pt)
ZA (2)	ZA200909003B (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2872962T3 (es) *	2005-02-16	2021-11-03	Anacor Pharmaceuticals Inc	Boronoftalidas para uso terapéutico
US7767657B2 (en)	2005-02-16	2010-08-03	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
RU2642628C2 (ru)	2006-02-16	2018-01-25	Анакор Фармасьютикалз, Инк.	Бор-содержащие малые молекулы в качестве противовоспалительных средств
BRPI0711155A2 (pt)	2006-05-02	2011-08-23	Anacor Pharmaceuticals Inc	terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
EP3246034A1 (en)	2008-03-06	2017-11-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
US20100256092A1 (en) *	2008-05-12	2010-10-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US8461336B2 (en)	2008-09-04	2013-06-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010027975A1 (en) *	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US9493489B2 (en)	2008-10-15	2016-11-15	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
SG172040A1 (en)	2008-12-17	2011-07-28	Anacor Pharmaceuticals Inc	Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
WO2010132833A1 (en) *	2009-05-14	2010-11-18	The Regents Of The University Of Michigan	Streptococcus vaccine compositions and methods of using the same
EP2458995A1 (en) *	2009-07-28	2012-06-06	Anacor Pharmaceuticals, Inc.	Trisubstituted boron-containing molecules
AP4039A (en)	2009-08-14	2017-02-28	Daitao Chen	Boron-containing small molecules as antiprotozoal agents
WO2011019616A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011019612A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US20110207701A1 (en) *	2009-08-19	2011-08-25	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) *	2009-09-25	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron containing small molecules
US8979820B2 (en)	2009-10-09	2015-03-17	Cynthia S. Bailey	Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
WO2011049971A1 (en)	2009-10-20	2011-04-28	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US8461134B2 (en)	2009-11-11	2013-06-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011116348A1 (en)	2010-03-19	2011-09-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agent
AU2011237681B2 (en) *	2010-04-07	2015-01-22	Glaxosmithkline Llc	Process for preparing benzoxaboroles
DK2613788T3 (en) *	2010-09-07	2017-08-07	Anacor Pharmaceuticals Inc	BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
WO2013025975A1 (en) *	2011-08-17	2013-02-21	Glaxosmithkline Llc	Combination treatments for hepatitis c
US9162999B2 (en)	2011-09-28	2015-10-20	Wisconsin Alumni Research Foundation	Catalytic conversion of cellulose to fuels and chemicals using boronic acids
AR088668A1 (es)	2011-11-21	2014-06-25	Lilly Co Eli	Moleculas pequeñas que contienen boro
AR088669A1 (es)	2011-11-21	2014-06-25	Lilly Co Eli	Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
US8530452B2 (en)	2011-12-22	2013-09-10	Micurx Pharmaceuticals, Inc.	Tricyclic boron compounds for antimicrobial therapy
WO2013154759A1 (en)	2012-04-14	2013-10-17	Anacor Pharmaceuticals, Inc.	Benzoxaborole compounds and uses thereof
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
AR094666A1 (es)	2013-01-30	2015-08-19	Dow Agrosciences Llc	Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas
US8778365B1 (en)	2013-01-31	2014-07-15	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9452173B2 (en)	2013-01-31	2016-09-27	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9446131B2 (en)	2013-01-31	2016-09-20	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9433680B2 (en)	2013-01-31	2016-09-06	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
AP2015008638A0 (en)	2013-02-01	2015-08-31	Anacor Pharmaceuticals Inc	Boron-containing small molecules as antiprotozoal agents
AU2014202928B1 (en) *	2013-06-05	2014-09-11	Agrofresh Inc.	Compounds and compositions
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) *	2013-08-09	2016-09-01	Glaxosmithkline Intellectual Property (No.2) Limited	Tricyclic benzoxaborole compounds and uses thereof
EA038093B1 (ru) *	2013-12-20	2021-07-05	Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед	Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
BR112016018483A2 (pt) *	2014-02-17	2018-07-10	Syngenta Participations Ag	benzoxaboróis ativos do ponto de vista microbicida
CN106459097A (zh) *	2014-07-01	2017-02-22	第三共株式会社	作为抗菌剂的三环苯并氧杂硼杂环戊烯类
US9738664B2 (en) *	2014-10-29	2017-08-22	Wisconsin Alumni Research Foundation	Boronic acid inhibitors of HIV protease
MA41495A (fr)	2015-02-12	2017-12-19	Anacor Pharmaceuticals Inc	Composés benzoxaborole et leurs utilisations
CA2981773C (en)	2015-04-09	2022-03-15	The Penn State Research Foundation	Synergistic benzoxaborole-containing anti-fungicidal composition
WO2017024022A1 (en) *	2015-08-06	2017-02-09	The Penn State Research Foundation	Benzoxaborole-containing coating resistant to cellulose-supportable fungus
CN109152932B (zh)	2016-03-02	2021-09-28	比尔及梅琳达盖茨基金会	含硼小分子
US10874679B2 (en)	2016-03-02	2020-12-29	Bill & Melinda Gates Foundation	Boron-containing small molecules
US10611780B2 (en)	2016-03-02	2020-04-07	Bill And Melinda Gates Foundation	Boron-containing small molecules
WO2017155879A1 (en)	2016-03-07	2017-09-14	Agrofresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
PE20190119A1 (es)	2016-05-12	2019-01-17	Anacor Pharmaceuticals Inc	Esteres de oxaborol y sus usos
US10961261B2 (en)	2017-03-01	2021-03-30	Anacor Pharmaceuticals, Inc.	Oxaborole analogs and uses thereof
CN107090000B (zh) *	2017-04-27	2019-07-12	上海交通大学	一种苯并硼唑7位脂肪酸的衍生物及其制备与用途
FI4265332T3 (fi)	2017-06-13	2025-05-21	Veterinary Diagnostics Inst Inc	Järjestelmä ja menetelmä verinäytteiden stabiloimiseksi, säilyttämiseksi ja ottamiseksi talteen
US20190159457A1 (en) *	2017-11-30	2019-05-30	Boragen, Inc.	Combinatorial Compositions of Benzoxaboroles and Biologic Agents
MX2020005464A (es) *	2017-11-30	2020-12-03	Boragen Inc	Compuestos de benzoxaborol y formulaciones de los mismos.
EP3836938A4 (en)	2018-08-18	2022-05-11	Boragen, Inc.	SOLID FORMS OF SUBSTITUTED BENZOXAZOLE AND COMPOSITIONS THEREOF
AR116305A1 (es) *	2018-09-07	2021-04-21	Boragen Inc	Compuestos que contienen boro y sus usos
US11058695B2 (en) *	2019-11-08	2021-07-13	Myongji University Industry And Academia Cooperation Foundation	Inhibitor of carbapenem-hydrolyzing class D beta-lactamases
WO2022043936A1 (en)	2020-08-31	2022-03-03	Pfizer Inc.	Methods of protecting rna
WO2023076453A1 (en) *	2021-10-29	2023-05-04	An2 Therapeutics, Inc.	Treating neuroinflammatory conditions
JP2025520237A (ja) *	2022-06-23	2025-07-03	ミクウルクファーマシューティカルズ，インコーポレイテッド	ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
CA3239097A1 (en)	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Prodrugs of boron compounds and their use in treating bacterial infections
US12482208B2 (en)	2023-05-30	2025-11-25	Snap Inc.	Mirroring 3D assets for virtual experiences

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en) *	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
GB1396904A (en)	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US5962498A (en) *	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4919934A (en)	1989-03-02	1990-04-24	Richardson-Vicks Inc.	Cosmetic sticks
US5594151A (en) *	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US6083903A (en) *	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
US5831046A (en) *	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
US6306628B1 (en) *	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
AU7995300A (en) *	1999-10-05	2001-05-10	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
WO2002006316A2 (en) *	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
US6537733B2 (en) *	2001-02-23	2003-03-25	Applied Materials, Inc.	Method of depositing low dielectric constant silicon carbide layers
GB0117645D0 (en) *	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de)	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
US7217701B2 (en) *	2001-10-11	2007-05-15	Katsuhiko Mikoshiba	Intracellular calcium concentration increase inhibitors
CN1325504C (zh)	2002-01-10	2007-07-11	宾夕法尼亚州研究基金会	制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
UA80131C2 (en) *	2002-05-28	2007-08-27	Dimensional Pharm Inc	Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
CN1829521B (zh) *	2003-06-16	2011-01-26	安纳考尔医药公司	耐水解的含硼治疗剂和使用方法
CN1980694B (zh) *	2004-05-12	2012-09-26	布赖汉姆妇女医院有限公司	凝溶胶蛋白治疗感染的用途
US7767657B2 (en)	2005-02-16	2010-08-03	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
ES2872962T3 (es) *	2005-02-16	2021-11-03	Anacor Pharmaceuticals Inc	Boronoftalidas para uso terapéutico
RU2642628C2 (ru) *	2006-02-16	2018-01-25	Анакор Фармасьютикалз, Инк.	Бор-содержащие малые молекулы в качестве противовоспалительных средств
US20070286822A1 (en) *	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
BRPI0713010A2 (pt) *	2006-06-12	2012-10-09	Anacor Pharmaceuticals Inc	compostos para o tratamento de doença periodontal
DE102006038471A1 (de)	2006-08-17	2008-04-10	Wala-Heilmittel Gmbh	Platanencreme, Verfahren zu ihrer Herstellung und Verwendung
JO3396B1 (ar) *	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
US20100256092A1 (en) *	2008-05-12	2010-10-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules

2008
- 2008-06-18 JO JOP/2008/0288A patent/JO3396B1/ar active
- 2008-06-19 DK DK08825921.3T patent/DK2164331T3/da active
- 2008-06-19 JP JP2010513416A patent/JP5530923B2/ja active Active
- 2008-06-19 CN CN201410134063.6A patent/CN104017008A/zh active Pending
- 2008-06-19 EA EA200901617A patent/EA020530B1/ru not_active IP Right Cessation
- 2008-06-19 US US12/142,692 patent/US7816344B2/en active Active
- 2008-06-19 KR KR1020157021997A patent/KR20150100945A/ko not_active Abandoned
- 2008-06-19 NZ NZ582706A patent/NZ582706A/en unknown
- 2008-06-19 EP EP08825921.3A patent/EP2164331B1/en active Active
- 2008-06-19 SG SG2012045712A patent/SG182219A1/en unknown
- 2008-06-19 KR KR1020107001062A patent/KR101578351B1/ko active Active
- 2008-06-19 NO NO08825921A patent/NO2164331T3/no unknown
- 2008-06-19 ES ES08825921.3T patent/ES2655299T3/es active Active
- 2008-06-19 MX MX2015007480A patent/MX347688B/es unknown
- 2008-06-19 WO PCT/US2008/067550 patent/WO2008157726A1/en not_active Ceased
- 2008-06-19 CN CN200880101464.4A patent/CN101772302B/zh active Active
- 2008-06-19 AU AU2008265630A patent/AU2008265630B2/en active Active
- 2008-06-19 KR KR1020167009966A patent/KR101685656B1/ko active Active
- 2008-06-19 CA CA2692135A patent/CA2692135C/en active Active
- 2008-06-19 MY MYPI20095460A patent/MY162692A/en unknown
- 2008-06-19 BR BRPI0813450A patent/BRPI0813450B8/pt active IP Right Grant
- 2008-06-20 AR ARP080102661A patent/AR067105A1/es active IP Right Grant
- 2008-06-20 CL CL2008001855A patent/CL2008001855A1/es unknown
- 2008-06-20 UY UY31171A patent/UY31171A1/es unknown
- 2008-06-20 TW TW097123257A patent/TW200911822A/zh unknown
- 2008-06-20 PE PE2008001074A patent/PE20090840A1/es not_active Application Discontinuation
2009
- 2009-11-26 IL IL202379A patent/IL202379A/en active IP Right Grant
- 2009-12-11 DO DO2009000281A patent/DOP2009000281A/es unknown
- 2009-12-17 ZA ZA2009/09003A patent/ZA200909003B/en unknown
- 2009-12-18 CO CO09145296A patent/CO6251209A2/es not_active Application Discontinuation
2010
- 2010-01-15 MA MA32517A patent/MA31675B1/fr unknown
- 2010-01-18 CR CR11224A patent/CR11224A/es unknown
- 2010-07-30 US US12/848,051 patent/US8895534B2/en active Active
2011
- 2011-06-21 ZA ZA2011/04573A patent/ZA201104573B/en unknown
2014
- 2014-04-21 JP JP2014087397A patent/JP2014148531A/ja active Pending
- 2014-11-07 US US14/536,483 patent/US9796735B2/en active Active
2015
- 2015-09-24 JP JP2015187239A patent/JP6570391B2/ja active Active
2017
- 2017-09-28 US US15/718,422 patent/US10533021B2/en active Active

Also Published As

Publication number	Publication date
US7816344B2 (en)	2010-10-19
JP5530923B2 (ja)	2014-06-25
US9796735B2 (en)	2017-10-24
CA2692135C (en)	2017-01-24
KR20160049025A (ko)	2016-05-04
US20100292504A1 (en)	2010-11-18
BRPI0813450B8 (pt)	2021-05-25
CN101772302A (zh)	2010-07-07
WO2008157726A1 (en)	2008-12-24
TW200911822A (en)	2009-03-16
MX347688B (es)	2017-05-09
EP2164331A1 (en)	2010-03-24
US10533021B2 (en)	2020-01-14
US8895534B2 (en)	2014-11-25
ES2655299T3 (es)	2018-02-19
EA200901617A1 (ru)	2010-06-30
EP2164331B1 (en)	2017-11-29
KR101578351B1 (ko)	2015-12-17
DK2164331T3 (da)	2018-01-29
AU2008265630B2 (en)	2013-06-20
CR11224A (es)	2010-06-28
ZA201104573B (en)	2014-03-26
US20150133402A1 (en)	2015-05-14
PE20090840A1 (es)	2009-07-08
JO3396B1 (ar)	2019-10-20
CL2008001855A1 (es)	2009-05-29
ZA200909003B (en)	2022-03-30
KR20150100945A (ko)	2015-09-02
JP2016040275A (ja)	2016-03-24
JP2010530881A (ja)	2010-09-16
CA2692135A1 (en)	2008-12-24
IL202379A (en)	2016-02-29
EA020530B1 (ru)	2014-11-28
NZ582706A (en)	2012-07-27
UY31171A1 (es)	2009-04-30
KR101685656B1 (ko)	2016-12-12
NO2164331T3 (pt)	2018-04-28
AR067105A1 (es)	2009-09-30
BRPI0813450B1 (pt)	2019-05-07
CO6251209A2 (es)	2011-02-21
CN104017008A (zh)	2014-09-03
US20090227541A1 (en)	2009-09-10
JP6570391B2 (ja)	2019-09-04
SG182219A1 (en)	2012-07-30
DOP2009000281A (es)	2010-07-31
US20180016285A1 (en)	2018-01-18
CN101772302B (zh)	2014-05-07
KR20100051615A (ko)	2010-05-17
MA31675B1 (fr)	2010-09-01
MY162692A (en)	2017-07-14
AU2008265630A1 (en)	2008-12-24
IL202379A0 (en)	2010-06-30
JP2014148531A (ja)	2014-08-21
EP2164331A4 (en)	2011-09-07

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-08	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-07-03	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-10-16	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-03-06	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-05-07	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2021-09-08	B15V	Prolongation of time limit allowed
2024-09-24	B25D	Requested change of name of applicant approved	Owner name: ANACOR PHARMACEUTICALS, LLC (US)
2024-10-08	B25G	Requested change of headquarter approved	Owner name: ANACOR PHARMACEUTICALS, LLC (US)
2024-10-22	B25G	Requested change of headquarter approved	Owner name: ANACOR PHARMACEUTICALS, LLC (US)

Publication	Publication Date	Title
BRPI0820568A2 (pt)	2015-06-16	Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BRPI0908124A2 (pt)	2015-08-04	Composto, ativador de glucoquinase, composição farmacêutica, uso de um composto ou sal farmacologicamente aceitavél do mesmo, e, métodos de ativação da glucoquinase, e para tratar e/ou prevenir uma doença
BRPI1009860A2 (pt)	2016-03-08	composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
BRPI1012219A2 (pt)	2016-03-29	produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para prevenir formação de biofilme em um ambiente, para tratar uma infecção microbiana por profilaxia ou terapia, e para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
BRPI0811542A2 (pt)	2014-11-18	Composto, formulação farmacêutica, uso de um composto, e, métodos para inibir a atividade de bace, e para tratar ou prevenir uma patologia relacionada com abeta em um mamífero composto, formulação farmacêutica, uso de um composto, e, métodos para inibir a atividade de bace, e, para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
BRPI0822162A8 (pt)	2015-09-22	método para tratamento de doenças das unhas ou leito ungueal e composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal.
BRPI1009920A2 (pt)	2016-03-15	composições bacterianas para profilaxina e tratamento de doença degenerativa.
BRPI1013705A2 (pt)	2016-04-05	compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0923758A2 (pt)	2015-08-04	"derivados de pirimidina e seu emprego para o combate ao crescimento indesejado de plantas".
BRPI1004899A2 (pt)	2016-04-05	composto, composição farmacêutica, método para tratar uma doença ou distúrbio relacionado a pi3k em um indivíduo necessitando do mesmo, método para tratar uma doença mediada por mtor, método para tratar ambas as doenças mediadas por pi3k e hdac
BRPI0911031B8 (pt)	2021-05-25	compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
BR112014010186A2 (pt)	2017-05-02	formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal
WO2010001169A3 (en)	2010-08-05	Chemical compounds 251
BRPI0920261A2 (pt)	2015-08-04	Composto, composição farmacêutica, uso do composto, e, método para inibir ou modular atividade de proteína quinase em uma amostra biológica
BRPI0816097A2 (pt)	2016-11-01	composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
BRPI0820068A2 (pt)	2015-09-01	Composição para nutrição humana e/ou animal, usos derivados e leveduras
BRPI0913300A2 (pt)	2018-05-22	composto, processo para o preparo e uso do mesmo, método de tratamento de infecção bacteriana em um animal, e, composição farmacêutica.
BR112012003464A2 (pt)	2015-09-08	composto, composição farmacêutica, usos de uma composição farmacêutica e de um composto, e, método para tratar uma doença ou um distúrbio."
BR112013014189A8 (pt)	2018-01-09	composição farmacêutica, uso de um agente de potencialização e uso de uma composição
BRPI0910359A2 (pt)	2015-09-22	método para inibir o crescimento de microorganismos e composição biocida
BRPI1009741A2 (pt)	2016-03-15	composição, método para prevenir ou tratar a mucosite em paciente mamífero, composição farmacêutica para adminstração tópica, e uso de uma composição
BRPI0916043A2 (pt)	2015-11-10	composição farmacêutica e alimento funcional para prevenir ou tratar câncer
BRPI0915471A2 (pt)	2017-06-27	composto, composição farmacêutica, métodos de inibir dna girase bacteriana e/ou topoisomerase bacteriana iv, para produzir um efeito antibacteriano em um animal de sangue quente e para tratar uma infecção bacteriana em um animal de sangue quente, e, uso de um composto
BRPI0811534A2 (pt)	2014-11-18	Composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticametne aceitável do mesmo.
BRPI0813159A2 (pt)	2014-12-30	Composição parasiticida veterinária, método para o tratamento ou controle de uma infecção ou infestação parasiticidas em um animal homeotérico, e, uso de uma composição